Annual Working Capital
$10.49 M
-$1.14 M-9.81%
31 December 2023
Summary:
Galmed Pharmaceuticals annual working capital is currently $10.49 million, with the most recent change of -$1.14 million (-9.81%) on 31 December 2023. During the last 3 years, it has fallen by -$19.69 million (-65.24%). GLMD annual working capital is now -88.04% below its all-time high of $87.70 million, reached on 31 December 2018.GLMD Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$15.17 M
+$6.65 M+78.02%
30 September 2024
Summary:
Galmed Pharmaceuticals quarterly working capital is currently $15.17 million, with the most recent change of +$6.65 million (+78.02%) on 30 September 2024. Over the past year, it has increased by +$4.68 million (+44.64%). GLMD quarterly working capital is now -83.27% below its all-time high of $90.67 million, reached on 30 June 2018.GLMD Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GLMD Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +44.6% |
| 3 y3 years | -65.2% | -49.7% |
| 5 y5 years | -84.9% | -78.2% |
GLMD Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -65.2% | at low | -49.7% | +114.8% |
| 5 y | 5 years | -84.9% | at low | -78.2% | +114.8% |
| alltime | all time | -88.0% | +782.9% | -83.3% | +1087.7% |
Galmed Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $15.17 M(+78.0%) |
| June 2024 | - | $8.52 M(-9.5%) |
| Mar 2024 | - | $9.42 M(-10.2%) |
| Dec 2023 | $10.49 M(-9.8%) | $10.49 M(-13.4%) |
| Sept 2023 | - | $12.11 M(+71.4%) |
| June 2023 | - | $7.06 M(-29.6%) |
| Mar 2023 | - | $10.03 M(-13.7%) |
| Dec 2022 | $11.63 M(-61.5%) | $11.63 M(-24.7%) |
| Sept 2022 | - | $15.45 M(-24.3%) |
| June 2022 | - | $20.40 M(-15.2%) |
| Mar 2022 | - | $24.05 M(-20.3%) |
| Dec 2021 | $30.18 M(-31.1%) | $30.18 M(-19.2%) |
| Sept 2021 | - | $37.34 M(-16.4%) |
| June 2021 | - | $44.66 M(-15.0%) |
| Mar 2021 | - | $52.56 M(+20.0%) |
| Dec 2020 | $43.80 M(-37.0%) | $43.80 M(-17.8%) |
| Sept 2020 | - | $53.29 M(-10.4%) |
| June 2020 | - | $59.50 M(-6.7%) |
| Mar 2020 | - | $63.76 M(-8.3%) |
| Dec 2019 | $69.50 M | $69.50 M(-9.8%) |
| Sept 2019 | - | $77.09 M(-4.9%) |
| June 2019 | - | $81.05 M(-4.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $84.57 M(-3.6%) |
| Dec 2018 | $87.70 M(+473.1%) | $87.70 M(-3.1%) |
| Sept 2018 | - | $90.46 M(-0.2%) |
| June 2018 | - | $90.67 M(+588.5%) |
| Mar 2018 | - | $13.17 M(-14.0%) |
| Dec 2017 | $15.30 M(+37.2%) | $15.30 M(+149.5%) |
| Sept 2017 | - | $6.13 M(+6.0%) |
| June 2017 | - | $5.79 M(-29.2%) |
| Mar 2017 | - | $8.17 M(-26.7%) |
| Dec 2016 | $11.15 M(-46.5%) | $11.15 M(-29.5%) |
| Sept 2016 | - | $15.81 M(+14.5%) |
| June 2016 | - | $13.81 M(-19.7%) |
| Mar 2016 | - | $17.20 M(-17.5%) |
| Dec 2015 | $20.84 M(-32.8%) | $20.84 M(-14.4%) |
| Sept 2015 | - | $24.34 M(-8.8%) |
| June 2015 | - | $26.69 M(-7.7%) |
| Mar 2015 | - | $28.92 M(-6.8%) |
| Dec 2014 | $31.03 M(-2120.4%) | $31.03 M(-5.5%) |
| Sept 2014 | - | $32.84 M(-10.7%) |
| June 2014 | - | $36.77 M(-4.2%) |
| Mar 2014 | - | $38.37 M(-2597.7%) |
| Dec 2013 | -$1.54 M(-801.4%) | -$1.54 M |
| Dec 2012 | $219.00 K | - |
FAQ
- What is Galmed Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals quarterly working capital year-on-year change?
What is Galmed Pharmaceuticals annual working capital?
The current annual working capital of GLMD is $10.49 M
What is the all time high annual working capital for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high annual working capital is $87.70 M
What is Galmed Pharmaceuticals quarterly working capital?
The current quarterly working capital of GLMD is $15.17 M
What is the all time high quarterly working capital for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high quarterly working capital is $90.67 M
What is Galmed Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, GLMD quarterly working capital has changed by +$4.68 M (+44.64%)